昆徐安比配方通过AhR/ROS/ERK通路抑制了佐[a]烯诱导的恶化喘气道粘液分泌
Bo-Han Wang1, Ling-Ling Tang2, Xian-Hong Sun1
1Affiliated Hospital of Nanjing University of Chinese Medicine/ Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, Jiangsu Province, China.
Journal of ethnopharmacology
|September 21, 2023
概括
昆峰比配方 (QFXBF) 有效地降低了气道粘液分泌在喘加剧空气污染物,如[a]烯 (BaP). 这种传统配方通过抑制酸受体 (AhR) /反应性氧物种 (ROS) /细胞外信号调节激酶 (ERK) 信号通路而起作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 环境健康 环境健康
背景情况:
- 空气污染通过增加气道粘液分泌而加剧喘.
- 曲徐安比配方 (QFXBF) 是一种用于治疗喘的中国传统药物.
- QFXBF对空气污染引起的粘液高分泌的影响尚未得到充分证实.
研究的目的:
- 为了研究QFXBF在减轻粘液分泌中的疗效,在子[a]皮林 (BaP) 加重的喘的小鼠模型中.
- 阐明QFXBF对BaP诱导的气道粘液产生作用的潜在机制.
主要方法:
- 通过使用卵胺 (OVA) 和BaP联合暴露,建立了一种恶化喘的小鼠模型.
- 评估肺功能 (Penh),血清IgE和肺组织病理学.
- 利用暴露于BaP的16HBE细胞来研究QFXBF对MUC5AC表达,ROS产生以及酸受体 (AhR) /ERK信号通路的影响.
- 使用特定抑制剂 (SR1,NAC,U0126) 来探测信号级联.
主要成果:
- 在暴露于BaP的小鼠和细胞中,QFXBF显著改善了喘症状,减少了MUC5AC的表达,并抑制了ROS的产生.
- BaP暴露增加了AhR表达和ERK酸化,而QFXBF可以逆转这些表达和酸化.
- 抑制AhR,ROS和ERK信号通路的抑制剂降低了BaP诱导的MUC5AC表达.
- QFXBF证明了AhR/ROS/ERK通路的调节,导致粘液分泌减少.
结论:
- 在BaP诱导恶化的喘的小鼠模型中,QFXBF有效地改善了气道粘液分泌.
- 该机制涉及AhR/ROS/ERK信号通路的抑制.
相关概念视频
Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Antiasthma Drugs: Methylxanthines
261
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
261
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K


